Tuesday, March 17, 2026

KOSPI Soars 26.2% in February: What This Means for Asian Investors

South Korea's KOSPI index surged 26.2% in February while U.S. stocks declined, prompting a trend of capital outflow from the U.S. market.

PURITY OR PROPAGANDA? : Why Kim Jong Un Brought His Wife And Daughter To Praise Women’s “Unwavering Strength”

North Korea celebrates women's contributions in nation-building, highlighting their roles in key sectors and achievements on International Women's Day.

8 Countries Nationals “North Korea Nuclear Is Threat Factor, South-North Unification Is Difficult”

A survey shows global support for Korean reunification but doubts its feasibility, with varying perceptions across different countries.

Tag: treatment

Novosis Trauma: The Game-Changing Bone Substitute Approved in Malaysia

CG MedTech's Novosis Trauma, a bone substitute for fractures, gains approval in Malaysia, marking its first international registration.

Understanding Neurogenic Bladder: Key Treatment Options for Asian Seniors in 2026

Neurogenic bladder affects many elderly patients. Early treatment is crucial to prevent complications. Options include catheterization and medication.

SK Chemicals’ Joins Tablet Surpasses 700 Billion KRW in Sales… What’s Behind the Osteoarthritis Drug’s Success?

SK Chemicals' Joins Tablets, a natural osteoarthritis treatment, surpasses 700 billion KRW in sales, marking a significant milestone in Korea.

NCCN Endorses Leclaza and Rybrevant Combo as Top Lung Cancer Treatment: What You Need to Know

NCCN guidelines now classify Leclaza + Rybrevant as a preferred first-line treatment for lung cancer, enhancing patient access and management.

Can a Keto Diet Cure Schizophrenia? Robert F. Kennedy Jr.’s Controversial Claims Examined

U.S. Health Secretary Kennedy claims the ketogenic diet can treat schizophrenia, but experts warn of unsupported evidence and health risks.

World Cancer Day 2026: How Patient-Centered Care is Transforming Cancer Treatment in Asia

The National Cancer Center joins a global campaign for World Cancer Day, promoting People-Centered Care through dialogue with patients.

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

How SK Chemical’s Nose-R Soft Cap Stand Out in Allergy Treatment: A Deep Dive into the OTC Market

SK Chemicals partners with Kyung Nam Pharm to enhance Nose-R Soft Cap sales in pharmacies, boosting allergy treatment distribution.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Male Breast Cancer Has More Than Doubled in 16 Years—So Why Haven’t Survival Rates Improved?

A study shows male breast cancer cases have doubled in 16 years, but survival rates remain low, highlighting treatment disparities.

What You Need to Know About Ganglion Cysts: Symptoms, Causes, and Treatments

Ganglion cysts are benign tumors on joints, often asymptomatic but may require treatment if painful. Regular wrist care is crucial.

How Tumor Microenvironment Stiffness Fuels Cancer Aggressiveness: Key Insights from Pusan National University

A study reveals that tumor microenvironment stiffness increases cancer aggressiveness and treatment resistance, highlighting its significance in treatment strategies.

How Ecrac Gel is Revolutionizing Axillary Hyperhidrosis Treatment in Korea: What You Need to Know

Dongwha Pharmaceutical launched Ecrac Gel, Korea's first prescription for underarm hyperhidrosis, promising effective relief for patients.

Unlocking Convenience: Rolvedon’s Same-Day Chemotherapy Solution for Neutropenia Revealed

Hanmi Pharmaceutical's Rolvedon shows potential for same-day chemotherapy administration, improving patient convenience and market competitiveness.

Top News

- Our Sponsors Ad -

Follow us